I cried with every single patient,” Sung says. “It just was this crazy feeling that, for the patients and families, almost can’t feel real.” The treatment, known as AMT-130, is delivered deep into the ...

Telix Pharmaceuticals Limited (NASDAQ:TLX) is among the best stocks with the highest upside potential. On September 10, 2025, ...

Groundbreaking study demonstrates that targeted oligodendrocyte gene therapy leads to decreased N-acetylaspartate (NAA) ...

Under the auspices of the US regulator, Imagion Biosystems hopes to launch a crucial phase II breast cancer imaging study by ...

Bayern Munich will go head-to-head against Pafos FC in the Champions League on Tuesday night as they travel to Cyprus for ...

For more than 60 years, the medical community has been refining the diagnosis of multiple sclerosis. The diagnosis of ...

The Chicago Cubs were still evaluating the extent of starter Cade Horton's back injury, leaving the National League Rookie of ...

As well as slowing disease progression by 75 percent at 36 months, the scientists found that neurofilament light protein (NfL)—a biomarker of neuronal damage—levels in spinal fluid were lower in ...

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and ...

Iopofosine I 131 is a potential first-in-class, novel cancer targeting agent utilizing a phospholipid ether as a ...

Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosisParis, September 22, 2025. The US ...